The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

In Brief

NCCS presents third annual Ellen Stovall Award to Gay Crawford and Norman Coleman

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

The National Coalition for Cancer Survivorship presented the third annual Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care to Gay Crawford, founding director of Cancer CAREpoint, and Norman Coleman, senior investigator at NCI.

Since her diagnosis of breast cancer at age 30, Crawford spent the last 44 years playing a leadership role in bringing patient-focused cancer care to the Silicon Valley area. She helped found and lead numerous organizations, including the non-profit organization Cancer CAREPoint, which provides a wide-range of cancer support services in Silicon Valley free of charge.

Coleman is the director of the Radiation Oncology Sciences Program. Coleman leads a laboratory at NCI focusing on radiation-induced molecular and immunotherapy targets.

Named for former NCCS CEO, Ellen Stovall, who died in 2016 due to complications from three cancer treatments, the award seeks to highlight those who continue Ellen’s work of transforming cancer care to further incorporate patients’ goals, needs, and values.

More information about Crawford, Coleman, and the Ellen Stovall Award can be found here.

Table of Contents

YOU MAY BE INTERESTED IN

Clinical

Oncofertility coverage mandates expand to 21 states and DC as political momentum builds
Gaps persist as patients face harrowing decisions and huge copays

The nagging pain in Mia Sandino’s right knee set in in September 2018, and throughout her freshman year at the University of Washington, she tried to ignore it. “I was being a very naive and invincible-feeling 19-year-old,” Sandino told The Cancer Letter. “I didn’t put two and two together that this area of the knee that...

By Claire Marie Porter and Sara Willa Ernst
Guest Editorial

My introduction to, and lessons learned from, Rick Pazdur

Rick Pazdur, MD, the newly appointed director for the Center for Drug Evaluation and Research at the FDA, has been described as “greyhound thin” as a result of his dedication to cycling and lifting weights in the gym each day and, for a long time, a vegetarian diet. I first met him when he was the director of the Office of Oncology Drug Products (ODP) within CDER, in 2009.
By Mikkael A. Sekeres
Sponsored

Meeting the moment: ASCO GI Cancers Symposium delivers insights and collaboration

When it comes to fighting cancer today, collaboration is key. At a time when funding is uncertain, yet innovative breakthroughs are accelerating every day, it’s more important than ever for oncologists, scientists, academic researchers, and community physicians, to come together to share knowledge and gain insights about the forefront of cancer research.
By The American Society of Clinical Oncology
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account